Stock Track | Beta Bionics Soars 41% on Nasdaq Debut Amid Strong IPO Demand

Stock Track

01/31

Shares of Beta Bionics, Inc. (BBNX) surged as much as 41.06% in intraday trading on Thursday, marking a stellar debut for the company's initial public offering (IPO) on the Nasdaq stock exchange.

The biotech firm, which specializes in developing advanced insulin delivery systems, saw its stock open at $22 per share, significantly higher than the $17 IPO pricing. The strong investor appetite drove the stock price up to $23.28 at its intraday peak, representing a remarkable gain of nearly 37% from the IPO level.

Beta Bionics' successful Nasdaq listing raised approximately $204 million in proceeds from the IPO, excluding the overallotment option. The company offered 12 million shares to the public, while granting underwriters an option to purchase an additional 1.8 million shares from the company and existing stockholders.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1108410193"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1108410193\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1108410193?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-31 01:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108410193","market":"hk","top_or_hot":-1,"title":"Stock Track | Beta Bionics Soars 41% on Nasdaq Debut Amid Strong IPO Demand","media":"Stock Track","content":"<p>Shares of Beta Bionics, Inc. (BBNX) surged as much as 41.06% in intraday trading on Thursday, marking a stellar debut for the company's initial public offering (IPO) on the Nasdaq stock exchange.</p>\n\n<p>The biotech firm, which specializes in developing advanced insulin delivery systems, saw its stock open at $22 per share, significantly higher than the $17 IPO pricing. The strong investor appetite drove the stock price up to $23.28 at its intraday peak, representing a remarkable gain of nearly 37% from the IPO level.</p>\n\n<p>Beta Bionics' successful Nasdaq listing raised approximately $204 million in proceeds from the IPO, excluding the overallotment option. The company offered 12 million shares to the public, while granting underwriters an option to purchase an additional 1.8 million shares from the company and existing stockholders.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Beta Bionics Soars 41% on Nasdaq Debut Amid Strong IPO Demand</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Beta Bionics Soars 41% on Nasdaq Debut Amid Strong IPO Demand\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-01-31 01:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Beta Bionics, Inc. (BBNX) surged as much as 41.06% in intraday trading on Thursday, marking a stellar debut for the company's initial public offering (IPO) on the Nasdaq stock exchange.</p>\n\n<p>The biotech firm, which specializes in developing advanced insulin delivery systems, saw its stock open at $22 per share, significantly higher than the $17 IPO pricing. The strong investor appetite drove the stock price up to $23.28 at its intraday peak, representing a remarkable gain of nearly 37% from the IPO level.</p>\n\n<p>Beta Bionics' successful Nasdaq listing raised approximately $204 million in proceeds from the IPO, excluding the overallotment option. The company offered 12 million shares to the public, while granting underwriters an option to purchase an additional 1.8 million shares from the company and existing stockholders.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BBNX","symbol_name":"Beta Bionics, Inc.","start_time":0,"source_url":"","article_id":"1108410193","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108410193","pubTimestamp":1738258708,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Beta Bionics, Inc.  surged as much as 41.06% in intraday trading on Thursday, marking a stellar debut for the company's initial public offering  on the Nasdaq stock exchange.The biotech firm, which specializes in developing advanced insulin delivery systems, saw its stock open at $22 per share, significantly higher than the $17 IPO pricing. The strong investor appetite drove the stock price up to $23.28 at its intraday peak, representing a remarkable gain of nearly 37% from the IPO lev","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BBNX":"Beta Bionics, Inc."},"translate_title":"由于IPO需求强劲，股票赛道Beta Bionics在纳斯达克首次亮相飙升41%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BBNX":1},"content_text":"Shares of Beta Bionics, Inc. (BBNX) surged as much as 41.06% in intraday trading on Thursday, marking a stellar debut for the company's initial public offering (IPO) on the Nasdaq stock exchange.\nThe biotech firm, which specializes in developing advanced insulin delivery systems, saw its stock open at $22 per share, significantly higher than the $17 IPO pricing. The strong investor appetite drove the stock price up to $23.28 at its intraday peak, representing a remarkable gain of nearly 37% from the IPO level.\nBeta Bionics' successful Nasdaq listing raised approximately $204 million in proceeds from the IPO, excluding the overallotment option. The company offered 12 million shares to the public, while granting underwriters an option to purchase an additional 1.8 million shares from the company and existing stockholders.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}